VICENTE
ESTRADA PÉREZ
Profesor asociado de Ciencias de la Salud
Hospital Sierrallana
Torrelavega, EspañaHospital Sierrallana-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Infectious Diseases and Therapy, Vol. 11, Núm. 3, pp. 1177-1192
2021
-
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
PloS one, Vol. 16, Núm. 4, pp. e0249515
-
Standardized comparison of cardiovascular risk factors prevalence in spanish women and men living with hiv and in the general population
Journal of Personalized Medicine, Vol. 11, Núm. 11
2017
-
Very low level viraemia and risk of virological failure in treated HIV-1-infected patients
HIV Medicine, Vol. 18, Núm. 3, pp. 196-203
2016
-
Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics
Open Forum Infectious Diseases, Vol. 3, Núm. 2